The pharmacologic inhibitor of PPP-like serine/threonine protein phosphatases, Okadaic acid (OA), has been identified as an EMT and tumor promoter in hepatocellular cellular carcinoma in vitro by a mechanism involving inhibition of PP2A [33]. The gene discussed is PTPA; the disease is neoplasm.